Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density

References

• Reszka AA, Rodan GA. Nitrogen-containing bisphosphonate mechanism of action. Mini Rev Med Chem 2004;4:711–19
   PubMed Web of Science ®Google Scholar
• Black DM, Thompson DE, Bauer DC, et al. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 2000;85:4118–24
   PubMed Web of Science ®Google Scholar
• Ensrud KE, Barrett-Connor EL, Schwartz A, et al. Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension. J Bone Miner Res 2004;19:1259–69
   PubMed Web of Science ®Google Scholar
• Bone HG, Hosking D, Devogelaer JP, et al. Ten years’ experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 2004;350:1189–99
   PubMed Web of Science ®Google Scholar
• National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases. NIH Consensus Statement – Osteoporosis Prevention, Diagnosis, and Therapy. Available on line at http://consensus.nih.gov/cons/111/111_ statement.htm. Accessed June 1, 2006
   Google Scholar
• Prevention, Calcium & Vitamin D. National Osteoporosis Foundation. Availabel online at http://www.nof.org/prevention/ calcium.htm. Accessed June 1, 2006
   Google Scholar
• Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 2005;115:3318–25
   PubMed Web of Science ®Google Scholar
• Reid IR, Ames RW, Evans MC, et al. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. Am J Med 1995;98:331–5
   PubMed Web of Science ®Google Scholar
• Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337: 670–6
   Google Scholar
• Prince RL, Devine A, Dhaliwal SS, Dick IM. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med 2006;166:869–75
   PubMed Web of Science ®Google Scholar
• Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992;327:1637–42
   PubMed Web of Science ®Google Scholar
• Recker RR, Hinders S, Davies KM, et al. Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res 1996;11:1961–6
   PubMed Web of Science ®Google Scholar
• Shea B, Wells G, Cranney A, et al. Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev 2002;23:552–9
   Google Scholar
• Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669–83
   PubMed Web of Science ®Google Scholar
• Dawson-Hughes B, Dallal GE, Krall EA, et al. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990;323:878–83
   Google Scholar
• Aloia JF, Vaswani A, Yeh JK, et al. Calcium supplementation with and without hormone replacement therapy to prevent post-menopausal bone loss. Ann Intern Med 1994;120:97–103
   PubMed Web of Science ®Google Scholar
• Prince RL, Smith M, Dick IM, et al. Prevention of post-menopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy. N Engl J Med 1991;325:1189–95
   Google Scholar
• Kamel S, Fardellone P, Meddah B, et al. Response of several markers of bone collagen degradation to calcium supplementation in postmenopausal women with low calcium intake. Clin Chem 1998;44:1437–42
   PubMed Web of Science ®Google Scholar
• Fardellone P, Brazier M, Kamel S, et al. Biochemical effects of calcium supplementation in postmenopausal women: influence of dietary calcium intake. Am J Clin Nutr 1998;67:1273–8
   PubMed Web of Science ®Google Scholar
• National Research Council. Recommended Dietary Allowances, 10th edn. Washington, DC: National Academy Press, 1989
   Google Scholar
• McAlister FA, Laupacis A, Wells GA, Sackett DL. Users’ Guides to the Medical Literature: XIX. Applying clinical trial results B. Guidelines for determining whether a drug is exerting (more than) a class effect. JAMA 1999;282:1371–7
   Google Scholar
• Bucher HC, Guyatt GH, Cook DJ, et al. Users’ Guides to the Medical Literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group. JAMA 1999;282:771–8
   Google Scholar
• Schnitzer T, Bone HG, Crepaldi G, et al. Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group. Aging (Milano ) 2000;12:1–12
   PubMedGoogle Scholar
• Genant HK, Grampp S, Gluer CC, et al. Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res 1994;9:1503–14
   PubMed Web of Science ®Google Scholar
• Rosen CJ, Hochberg MC, Bonnick SL, et al. Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study. J Bone Miner Res 2005;20:141–51
   PubMed Web of Science ®Google Scholar
• Bonnick S, Saag KG, Keil DP, et al. Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years. J Clin Endocrinol Metab 2006;91:2631–7
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Rizzoli R. Long-term experience with alendronate in the treatment of osteoporosis. Expert Opin Pharmacother 2006;7:1201–10
   PubMed Web of Science ®Google Scholar
• Riis B, Thomsen K, Christiansen C. Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study. N Engl J Med 1987;316:173–7
   Google Scholar
• Prestwood KM, Thompson DL, Kenny AM, et al. Low dose estrogen and calcium have an additive effect on bone resorption in older women. J Clin Endocrinol Metab 1999;84:179–83
   PubMed Web of Science ®Google Scholar
• Results of USDA’s 1994–1996 continuing survey of food intakes by individuals. USDA. Available on line at http://www. ars.usda.gov/Services/docs.htm?docid=7716#food. Accessed June 1, 2006
   Google Scholar
• Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 2000;15:1526–36
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Ross PD, Black D, et al. Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group. Arthritis Rheum 1999;42:1246–54
   PubMed Web of Science ®Google Scholar
• Bauer DC, Black DM, Garnero P, et al. Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial. J Bone Miner Res 2004;19:1250–8
   PubMed Web of Science ®Google Scholar
• Eastell R, Barton I, Hannon RA, et al. Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res 2003;18:1051–6
   PubMed Web of Science ®Google Scholar
• Cummings SR, Karpf DB, Harris F, et al. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 2002;112: 281–9
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Greenspan S, Wasnich RD, et al. Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. J Clin Endocrinol Metab 2002;87: 1586–92
   PubMed Web of Science ®Google Scholar
• Wasnich RD, Miller PD. Antifracture efficacy of antiresorptive agents are related to changes in bone density. J Clin Endocrinol Metab 2000;85:231–6
   PubMed Web of Science ®Google Scholar
• Finkelstein JS. Calcium plus vitamin D for postmenopausal women – bone appetit? N Engl J Med 2006;354:750–2
   PubMed Web of Science ®Google Scholar
• Office of Dietary Supplements NIH Clinical Center. Dietary Supplement Fact Sheet: Vitamin D. Available on line at http://dietary-supplements.info.nih.gov/factsheets/vitamind. asp. Accessed June 1, 2006
   Google Scholar